Literature DB >> 17532066

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis.

Bengt Johansson1, Stellan Mörner, Anders Waldenström, Per Stål.   

Abstract

OBJECTIVE: To clarify the morphological basis of the limited coronary reserve in hypertrophic cardiomyopathy (HCM).
BACKGROUND: Some of the symptoms in Hypertrophic cardiomyopathy (HCM), such as chest pain, dyspnea and arrhythmia, may be explained by myocardial ischemia. Many patients with HCM are known to exhibit these symptoms in the absence of atherosclerosis in the major coronary vessels. Decreased myocardial perfusion has been demonstrated in HCM, however, little is known about the myocardial capillary morphology in this disease.
METHODS: Using immunohistochemistry and morphometry, we analysed capillaries and cardiomyocytes in myectomy specimens from 5 patients with HCM with moderate hypertrophy and left ventricular outflow tract obstruction and in 5 control hearts.
RESULTS: The number of capillaries per cardiomyocyte (p<0.009) and number of capillaries per cardiomyocyte area unit, reflecting cardiomyocyte mass (p=0.009), were lower in individuals with HCM, i.e. indicating loss of capillaries. In HCM, the capillary density was 33% lower (p<0.05).
CONCLUSIONS: Our morphologic findings show that the capillary supply, and thus the coronary reserve, is impaired in HCM with moderate hypertrophy and left ventricular outflow tract obstruction. These data may partly explain the limitation of myocardial perfusion in HCM, which is associated with worse prognosis. Furthermore, we present evidence of actual loss of myocardial capillaries in HCM and a defective capillary growth.

Entities:  

Mesh:

Year:  2007        PMID: 17532066     DOI: 10.1016/j.ijcard.2007.04.003

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.

Authors:  Justin P Zachariah; Steven D Colan; Peter Lang; John K Triedman; Mark E Alexander; Edward P Walsh; Charles I Berul; Frank Cecchin
Journal:  Circ Heart Fail       Date:  2012-05-24       Impact factor: 8.790

Review 2.  Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Aurelio Sgalambro; Massimo Baldi; Barbara Sotgia; Davide Antoniucci; Paolo G Camici; Roberto Sciagrà; Iacopo Olivotto
Journal:  J Cardiovasc Transl Res       Date:  2009-11-03       Impact factor: 4.132

3.  Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart.

Authors:  Wataru Kimura; Feng Xiao; Diana C Canseco; Shalini Muralidhar; SuWannee Thet; Helen M Zhang; Yezan Abderrahman; Rui Chen; Joseph A Garcia; John M Shelton; James A Richardson; Abdelrahman M Ashour; Aroumougame Asaithamby; Hanquan Liang; Chao Xing; Zhigang Lu; Cheng Cheng Zhang; Hesham A Sadek
Journal:  Nature       Date:  2015-06-22       Impact factor: 49.962

4.  Capillaries as a Therapeutic Target for Heart Failure.

Authors:  Yohko Yoshida; Ippei Shimizu; Tohru Minamino
Journal:  J Atheroscler Thromb       Date:  2022-04-01       Impact factor: 4.394

5.  Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?

Authors:  Paco E Bravo
Journal:  J Nucl Cardiol       Date:  2018-05-14       Impact factor: 5.952

Review 6.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

Review 7.  Targets for therapy in sarcomeric cardiomyopathies.

Authors:  Jil C Tardiff; Lucie Carrier; Donald M Bers; Corrado Poggesi; Cecilia Ferrantini; Raffaele Coppini; Lars S Maier; Houman Ashrafian; Sabine Huke; Jolanda van der Velden
Journal:  Cardiovasc Res       Date:  2015-01-29       Impact factor: 10.787

8.  Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.

Authors:  Robert Jablonowski; Eva Fernlund; Anthony H Aletras; Henrik Engblom; Einar Heiberg; Petru Liuba; Håkan Arheden; Marcus Carlsson
Journal:  Pediatr Cardiol       Date:  2015-06-12       Impact factor: 1.655

9.  Association between genetic variants in the HIF1A-VEGF pathway and left ventricular regional myocardial deformation in patients with hypertrophic cardiomyopathy.

Authors:  Guido E Pieles; Jaime Alkon; Cedric Manlhiot; Chun-Po Steve Fan; Caroline Kinnear; Leland N Benson; Seema Mital; Mark K Friedberg
Journal:  Pediatr Res       Date:  2020-05-06       Impact factor: 3.756

10.  Hyaluronan and collagen in human hypertrophic cardiomyopathy: a morphological analysis.

Authors:  Martin Hellström; Anna Engström-Laurent; Stellan Mörner; Bengt Johansson
Journal:  Cardiol Res Pract       Date:  2012-07-26       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.